PA
PRAH

Perceptive Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Perceptive Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,427
Closed -$566K – 163
2017
Q3 		$566K Buy
+7,427
New +$561K 0.02% 118
2017
Q2 		– Sell
-8,308
Closed -$542K – 171
2017
Q1 		$542K Buy
+8,308
New +$489K 0.03% 114
2016
Q2 		– Sell
-11,751
Closed -$502K – 214
2016
Q1 		$502K Buy
+11,751
New +$497K 0.04% 125

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors's PRAH Position: Q4 2017 in Review

Perceptive Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2017, closing a stake of 7,427 shares — an estimated $566K sold.

Perceptive Advisors first reported a position in PRAH in Q1 2016 and held it in 3 quarters. The position peaked at $566K in Q3 2017. 282 funds tracked by Wall St. Rank hold PRAH as of Q4 2017.

  • Perceptive Advisors reported no remaining PRA Health Sciences, Inc. position as of Q4 2017 after selling out during the quarter.
  • Perceptive Advisors sold 7,427 PRA Health Sciences, Inc. shares in Q4 2017, an estimated $566K.
  • Perceptive Advisors first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 3 quarters.
  • Perceptive Advisors's PRA Health Sciences, Inc. position peaked at $566K in Q3 2017.
  • 282 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2017.

Based on Perceptive Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.